Table 4.
Incidence of Adverse Events Occurring in more than 3% of Subjects
| Adverse Event | Placebo (n = 223) | Ramelteon (n = 228) |
|---|---|---|
| Headache | 18 (8.1) | 18 (7.9) |
| Upper respiratory tract infection | 6 (2.7) | 11 (4.8) |
| Nasopharyngitis | 11 (4.9) | 10 (4.4) |
| Urinary tract infection | 9 (4.0) | 9 (3.9) |
| Dizziness | 5 (2.2) | 7 (3.1) |
| Nausea | 8 (3.6) | 7 (3.1) |
Data are presented as number (%).